Gas chromatography–mass spectrometry (GC–MS) and ion chromatography profile wasabi and mustard heat and acidity.
|Webcasts|December 8, 2020
Regulatory Requirements and Analytical Strategies to Analyze Extractables and Leachables
Author(s)Agilent Technologies, Inc.
***Live: Europe: Tuesday, December 8, 2020 at 9am EST| 2pm GMT| 3pm CET US: Tuesday, December 8, 2020 at 2pm EST| 1pm CST| 11am PST***Pharmaceutical manufacturers have come under growing pressure to perform sensitive and accurate analytical studies to detect, identify, and quantify extractable and leachable compounds***On demand available after final airing until Dec. 8, 2021***
Register Free:
Event Overview: Pharmaceutical manufacturers have come under growing pressure to perform sensitive and accurate analytical studies to detect, identify, and quantify extractable and leachable compounds (E&Ls) which may be potentially toxic or have otherwise undesirable effects on the efficacy of drugs. Even as regulatory guidance related to the application, performance, and reporting of E&L studies increases and examples and data accumulate, E&L analysis is still an evolving area of investigation.
The webcast will provide recent regulatory updates for extractable and leachable studies for both medicinal devices and medical products. It will highlight similarities and differences between these similar but different regulations. The webinar will also cover the factors and decisions required to design and execute a successful study.
Key Learning Objectives:
Participants Will Learn:
- Recent regulatory updates about E&L studies
- Strategies for successful E&L studies
Speakers: Dr. Andrew Feilden, European E&L Strategic Director, Hall Analytical
Times and Dates: Europe: Tuesday, December 8, 2020 at 9am EST| 2pm GMT| 3pm CET
US: Tuesday, December 8, 2020 at 2pm EST| 1pm CST| 11am PST
On Demand until Dec. 8, 2021.
Sponsor: Agilent
Register free:
Related to this article
How feasible is it to integrate this Bayesian graph-theory methodology into existing commercial chromatography software workflows for semi-automated data curation in routine analytical laboratories?
Reversed-phase high-performance liquid chromatography (RP-HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) show frequent milking alters cobra venom toxin makeup.
Gabriel Vivó-Truyols outlines the benefits and challenges of combining graph theory with Bayesian statistics to automate peak assignment and alignment.
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.
Gabriel Vivó-Truyols from the Spanish Council for Scientific Research, Madrid, Spain. discusses his work on using graph theory and Bayesian statistics for peak assignment and chromatographic alignment.
Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
Trending on LCGC International
1
GLP-1 Peptide Analysis: Challenges and Solutions
2
HPLC–DAD Method Tracks Semaglutide and Tirzepatide Stability
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
LC–MS/MS Dried Blood Spot Test for Galactosemia
5